ESC Premium Access

Serum lipid profiles and uptake of lipid-lowering therapy in patients with premature atherosclerotic cardiovascular disease (ASCVD) in comparison to older patients with ASCVD

Congress Presentation

About the speaker

Professor Timothy Tan

Westmead and Blacktown Hospitals, Sydney (Australia)
1 presentation
0 follower

6 more presentations in this session

Angioprotein-like 3 and atheroma progression in statin-treated type 2 diabetic patients with coronary artery disease: the pre-specified analysis from the OPTIMAL randomized controlled trial.

Speaker: Doctor S. Kitahara (Kashiwa, JP)

Thumbnail

PCSK9 inhibitors in HIV patients with dyslipidemia

Speaker: Doctor S. Datla (Cleveland, US)

Thumbnail

Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease

Speaker: Doctor E. Aivalioti (Athens, GR)

Thumbnail

The effect of 6-month treatment with coenzyme Q10 on endothelial, vascular and myocardial function in patients with nonalcoholic fatty liver disease.

Speaker: Doctor I. Ikonomidis (Athens, GR)

Thumbnail

The association of steatotic liver disease with recurrent ischemic events in patients with chronic coronary syndrome: a multicenter cohort study

Speaker: Doctor G. Zeng (Beijing, CN)

Thumbnail

Access the full session

Liver metabolism and heart disease

Speakers: Professor T. Tan, Doctor S. Kitahara, Doctor S. Datla, Doctor E. Aivalioti, Doctor I. Ikonomidis...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations